This line of argument is misdirected. And ignores the key differences in approach and focus of the companies and is of limited value in predicting what is to come for NUH.
1) NUH bet big rightly or wongly on the OTC market being established, the OTC proposal was announced in 2017 and sign in by Trump with bi-partisan support. The expectation was that the category with bi-partisan support would be established within a reasonable and I dare say relatively short time frame and not be delayed and pushed out into late 2022. In hindsight, NUH would of been better served following a very different strategy, instead it was caught in a waiting game. This is all Harry Hindsight stuff now, interesting to troll over and debate but irrelevant. NUH is currently has the only product meeting QUH classification in the OTC space. They got something right, eventually.
2) The Amplifon example is a established relationship in the hearing space with the company in question, NUH prior relationships were essentially in the consumer bud market (with some hearing concerns sprinkled in) where they were trying to establish a "hearable" category but with a main focus on OTC. As in point 1, NUH appeared to be simply scrapping to make it to the OTC market. The recent announcments all have to do with establishing these OTC distribution channels, there is limited visibility at this stage. However, given they are the only product that meets QUH requirements at this stage and there are over 10k in POS , one is going to sell something. Making very conservative assumptions regarding the net POS, one still gets potential revenue numbers higher than NUH has ever had before even with very conservative assumptions. What also needs to be understood is a number of those POS's will include active sales. We have had the first batch shipped of a large production run, with more batches to come, my understanding is that numbers will be made available soon on total to date shipments rather than on the initial batch, hence the non disclosure.
3) Looking at the MAx's as a example for how the HP Pros will perform is misguided. Different product , different branding, different market context etc. Very few robust conclusions can be drawn. In fact NUH strategy now has far more coherence than anything presented over the past few years. That is why I have also stated, relying on the recent half yearly as a guide going forward tells you nothing.
4) The real action will be in the RealTek chip and OEM space. We are still awaiting the commercial details of this. For what ever reason people seem to be stuck on how many HP Pro buds may potentially be sold at a POS's ignoring that most of the money will be coming from these arrangements. In the company presentation they have stated the RealTek relationship (next generation chip, this will be driven by RealTek, they have put money directly into NUH but will also be funding the capex for chip production and distribution/implementation) and the expectation that they will close out at "least one" OEM, which suggests something is close.
5) For the first time NUH has 1) a coherent strategy and 2) a major backer in RealTek. NUH in 2023 onward is a completely different animal to NUH pre 2023. Compare currently to what existed during the period 2018-2022, where would you rather be?. As I stated previously, I thought the company would go under in 2022, in particular the first half. Their sales statergy was stuggling, there still was no FDA category, the Pro release was delayed awaiting FDA and they had little cash and no backer. Things have turned around completely in a very short space of time.
6) I do agree with you that NUH needs to be putting numbers up and be more transparent, I believe that will change particularly as the RealTek side of this partnership develops. In fact RealTek will demand it. I would not be surprised if a RealTek person comes on board in some capacity, they are a major shareholder and business partner, it would be expected, and if it does occur, that is a big positive for NUH.
I have seen this before, with struggling companies that turn around, it can take some time before people realise the new paradigm, their mind is still in the previous paradigm and I see this demonstrated in some of the posts, they are the same arguments from 2019-2022. Things have changed. Time to pay attention to whats in front and not to what is in the rear view mirror. .
Expand
(20min delay)